2021 Mount Himlung Ascent

Professor Niall Tebbutt is the Deputy Chair of the GI Cancer Institute & AGITG. He climbed Mt Kilimanjaro in 2015 and Mt Aconcagua in 2017 to raise funds for the GI Cancer Institute.

He is currently the Principal Investigator of the MODULATE and LIBERATE clinical trials conducted by the GI Cancer Institute, finding the best treatments for bowel cancer patients. 

In 2021, Niall and team will be taking on another high altitude, extreme mountaineering climb, ascending to extraordinary heights. This time they will scale the 7,126m mountain Mt Himlung Himal in Nepal.

“We are undertaking this noteworthy Gutsy Challenge to raise funds to support innovative and vital research so that we can continue to provide better treatments for people living with GI Cancer,” said Professor Niall Tebbutt. “We need your support in helping us reach the top so that we can achieve our ultimate aim of making GI cancer a disease of the past.”

Mt Himlung Himal is located in the Manaslu region of Nepal, which is considered one of the most remote corners of the mountain country at the border between Nepal and Tibet. The climb is a steep and icy ascent, and since its opening in 1992 only a handful of teams have successfully completed it. 

Following months of training, including ‘practice’ climbs scaling icy peaks in New Zealand, to master the technical expertise and fitness level that is required to climb Mt Himlung Himal, the team will take on the 28 day climb to reach the summit.

This is a remarkable effort on the part of the members of this team to raise much needed funds for GI cancer research.

Click the donate button above to support Niall on this Gutsy Challenge. 

GI cancer includes cancer of the oesophagus, stomach, liver, gallbladder and biliary tract, pancreas, large and small bowel and rectum and anus. 

Over 28,900 Australians are diagnosed every year, with 38 Australians dying every day.

Click the home button to read more about this Gutsy Challenge and see the rest of the team.